This inventor holds 1 USPTO granted patent. Top assignee: Teijin Pharma Limited. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: The Innovations of Robert Dale Mitchell
Introduction
Robert Dale Mitchell is a notable inventor based in Walden, GB. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on pyrazolo[1,5-A] pyrimidine derivatives. His research focuses on developing compounds that exhibit excellent kinase inhibiting activity, which has important implications for treating various diseases.
Latest Patents
Mitchell holds a patent for pyrazolo[1,5-A] pyrimidine derivatives. These compounds, represented by formula I, and their pharmaceutically acceptable salts are expected to be effective as therapeutic or prophylactic agents for disorders mediated by protein kinases. This includes conditions such as inflammatory diseases, autoimmune diseases, destructive bone disorders, cancer, and tumor growth.
Career Highlights
Robert Dale Mitchell is associated with Teijin Pharma Limited, where he continues to advance his research and development efforts. His work has the potential to lead to significant breakthroughs in the treatment of serious health conditions.
Collaborations
Mitchell has collaborated with esteemed colleagues, including Kenichiro Kataoka and Naotaka Suzuki. Their combined expertise enhances the innovative potential of their projects.
Conclusion
Robert Dale Mitchell's contributions to the field of pharmaceuticals through his patent on pyrazolo[1,5-A] pyrimidine derivatives highlight his role as a key innovator. His work promises to impact the treatment of various diseases significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile